What is going on in TN – a deeper look? And What’s Up with CVS?
Texas Medicaid is not one system—it is a collection of regional ecosystems, each with distinct MCO dynamics, provider performance expectations, and contract structures.
Most organizations fail by trying to scale a centralized model.
-
It’s About PBM Regulation (Not Store Profitability)
The core issue is proposed Tennessee legislation (often called the “Fair Rx Act”) that would:Ban companies from owning BOTH:
- A pharmacy
- AND a pharmacy benefit manager (PBM)
That directly targets CVS Health because:
- CVS owns retail pharmacies
- AND its PBM, Caremark
If the law passes:
- CVS would have to choose one or the other
- Or exit the state entirely
-
Why This Matters: The PBM Model Is the Profit Engine
PBMs (like Caremark) are the economic backbone of companies like CVS.They:
- Negotiate drug prices
- Control reimbursement rates
- Manage formularies
- Influence where prescriptions are filled
Owning BOTH PBM + pharmacy allows CVS to:
- Control pricing
- Capture margin across the value chain
- Steer volume into its own pharmacies
-
Why Tennessee Is Pushing This
State lawmakers and independent pharmacies argue:
- PBMs create conflicts of interest
- Large chains (like CVS) undercut independent pharmacies
- Reimbursement rates are unfair and opaque
The legislation aims to:
- “Level the playing field”
- Increase transparency
- Protect local pharmacies
-
Why CVS Is Fighting So Hard
From CVS’s perspective:
- Losing PBM + pharmacy integration = losing margin
- Their entire model depends on end-to-end control
- Separating the two could make many stores financially unviable
That’s why CVS has:
- Warned of closures
- Launched ad campaigns
- Said access to care could be disrupted
-
The Bigger Picture (This Is What Matters for You)
This is not just about Tennessee.This is a national inflection point:
What’s happening:
- States are challenging PBM power
- Pharmacy economics are under regulatory scrutiny
- Medicaid + commercial drug spend is under pressure
What it means:
- Pharmacy is becoming a margin battleground
- Vertical integration is being questioned
- Health plans and providers will need to rethink pharmacy strategy
Executive Takeaway
“The CVS situation in Tennessee isn’t about store closures—it’s about the unraveling of the vertically integrated pharmacy-PBM model. As states push for transparency and fairness, organizations that rely on that structure will need to redesign how they manage pharmacy cost, access, and margin.”